Education
About Us
Working with TipRanks
Follow Us
RegenXBio (RGNX)
NASDAQ:RGNX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 170.44M | $ 83.33M | $ 90.24M | $ 112.72M | $ 470.35M |
| Gross Profit | $ 150.14M | $ 49.76M | $ 53.03M | $ 58.18M | $ 418.51M |
| Operating Income | $ -161.20M | $ -233.35M | $ -268.13M | $ -262.88M | $ 159.98M |
| EBITDA | $ -161.20M | $ -198.23M | $ -239.46M | $ -244.24M | $ 169.54M |
| Net Income | $ -193.88M | $ -227.10M | $ -263.49M | $ -280.32M | $ 127.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 230.07M | $ 234.69M | $ 275.26M | $ 364.64M | $ 457.44M |
| Total Assets | $ 453.03M | $ 465.99M | $ 573.97M | $ 833.27M | $ 1.11B |
| Total Debt | $ 73.50M | $ 82.03M | $ 89.29M | $ 94.80M | $ 86.68M |
| Net Debt | $ 39.03M | $ 24.51M | $ 54.77M | $ -2.15M | $ -258.53M |
| Total Liabilities | $ 350.30M | $ 206.34M | $ 262.23M | $ 317.07M | $ 349.61M |
| Stockholders' Equity | $ 102.73M | $ 259.65M | $ 311.74M | $ 516.20M | $ 764.30M |
| Cash Flow | |||||
| Free Cash Flow | $ -126.38M | $ -175.56M | $ -228.37M | $ -238.21M | $ 134.70M |
| Operating Cash Flow | $ -123.96M | $ -173.13M | $ -218.41M | $ -207.49M | $ 218.88M |
| Investing Cash Flow | $ -15.87M | $ 103.45M | $ 190.94M | $ -11.93M | $ -406.64M |
| Financing Cash Flow | $ 116.77M | $ 92.68M | $ -34.97M | $ -28.84M | $ 195.25M |